FIELD: medicine.
SUBSTANCE: method involves studying vascular endothelial growth factor in patient blood serum during planned preoperative examination. The value being equal to or greater than 1.51 ng/ml, hypertrophic cicatrix development is predicted to take place after mammoplasty operation.
EFFECT: high accuracy and objectivity of cosmetic result prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RESULT OF LASER TREATMENT OF A HYPERTROPHIC SCAR IN WOMEN | 2021 |
|
RU2761893C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF SKIN SCAR TYPE IN WOMEN | 2017 |
|
RU2680085C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF KELOID SCAR | 2001 |
|
RU2193206C2 |
| METHOD FOR PREDICTION OF PATHOLOGICAL SCAR FORMATION ACCOMPANYING WOUND HEALING | 2018 |
|
RU2694009C1 |
| METHOD FOR TREATING COMPLICATIONS AFTER APPLYING HYDROGEL ENDOPROSTHESES | 2000 |
|
RU2182466C1 |
| METHOD FOR TREATING HEAD AND NECK HYPERTROPHIC AND KELOID SCARS | 2020 |
|
RU2744669C1 |
| METHOD OF TREATING THE PATIENTS WITH SCARRING SKIN LESIONS | 2019 |
|
RU2712183C1 |
| METHOD FOR TREATING THE CASES OF HYPERTROPHIC AND KELOID SKIN CICATRICES | 2002 |
|
RU2234963C2 |
| METHOD OF ELIMINATING OLD, MULTIPLY TREATED AND X-RAY RESISTANT FALSE KELOIDS | 2010 |
|
RU2452533C2 |
| METHOD OF SURGICAL TREATMENT OF NORMOTROPHIC AND HYPERTROPHIC PTOSIS OF THE MAMMARY GLANDS OF 2 OR 3 DEGREE | 2022 |
|
RU2808373C1 |
